Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment

被引：14

作者：

Lane, D ^{[1
]}

Lip, GYH ^{[1
]}

机构：

[1] Univ Dept Med, City Hosp, Birmingham B18 7QH, W Midlands, England

来源：

AGE AND AGEING | 2005年 / 34卷 / 01期

关键词：

D O I：

10.1093/ageing/afi008

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：1 / 3

页数：3

共 28 条

[1]

[Anonymous], 2003, CARD ARRHYTHMIAS H S

[2]

[Anonymous], 2013, COMPETITION COLLABOR

[3]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[4]

BERTAKIS KD, 1977, J FAM PRACTICE, V5, P217

[5] Why do patients with atrial fibrillation not receive warfarin? [J].

Bungard, TJ ;

Ghali, WA ;

Teo, KK ;

McAlister, FA ;

Tsuyuki, RT .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) :41-46

[6] The risk for and severity of bleeding complications in elderly patients treated with warfarin [J].

Fihn, SD ;

Callahan, CM ;

Martin, DC ;

McDonell, MB ;

Henikoff, JG ;

White, RH .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :970-+

[7] Avoidance hierarchies and preferences for anticoagulation-semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin [J].

Fuller, R ;

Dudley, N ;

Blacktop, J .

AGE AND AGEING, 2004, 33 (06) :608-611

[8] Risk communication and older people-understanding of probability and risk information by medical inpatients aged 75 years and older [J].

Fuller, R ;

Dudley, N ;

Blacktop, J .

AGE AND AGEING, 2001, 30 (06) :473-476

[9] Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].

Go, AS ;

Hylek, EM ;

Borowsky, LH ;

Phillips, KA ;

Selby, JV ;

Singer, DE .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (12) :927-+

[10]

HAMAAD A, 2004, BR J CARDIOL, V11, P229

← 1 2 3 →